Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. antibiotic treatment
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Antibiotic Treatment Articles & Analysis

38 news found

Infection Control Resources to Identify Shigella and Other Pathogens in Puerto Rico

Infection Control Resources to Identify Shigella and Other Pathogens in Puerto Rico

Fortunately, most people who get the infection get better without antibiotic treatment in 5 to 7 days, according to the agency.” Past outbreaks have taken place in healthcare centers, nursing homes, restaurants, water parks, schools, and daycare centers. ...

ByCochrane & Associates, LLC


Profacgen Updates Its Antimicrobial Peptides Services to Drive Innovation in Antimicrobial Research

Profacgen Updates Its Antimicrobial Peptides Services to Drive Innovation in Antimicrobial Research

Due to their unique mechanism of action, AMPs are increasingly seen as promising alternatives to traditional antibiotics, especially as antibiotic resistance continues to emerge and spread globally. ...

ByProfacgen


Alfa Chemistry Expands Portfolio with Diverse Alkaloids-Related Natural Products for Health, Nutrition Enhancement

Alfa Chemistry Expands Portfolio with Diverse Alkaloids-Related Natural Products for Health, Nutrition Enhancement

Their versatility extends to applications in cancer treatment and wound healing, making them a significant focus of biotechnological research. Antibiotics, natural products predominantly produced by microorganisms, hold a crucial role in combating infectious diseases. Alfa Chemistry’s portfolio includes a diverse collection of antibiotics ...

ByAlfa Chemistry


Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications

Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications

Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, unveils the addition of the reliable Daptomycin ReadyMade™ Solution to its growing portfolio of innovative products to power up spectrum and microbiology applications. Daptomycin is an essential antibiotic used in the treatment ...

ByAmerigo Scientific


MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

The company has launched the Phage Whole-Genome Sequencing to help discover biomarkers and develop non-antibiotic treatment methods. Phages are a group of viruses that invade bacteria, some of which can cause lysis of the host bacteria and some of which can confer additional biological properties to the genetic material of the host bacteria. ...

ByCD Genomics


Photodisinfection successfully eradicates pathogens associated with replacement joint infections

Photodisinfection successfully eradicates pathogens associated with replacement joint infections

Periprosthetic joint infections (PJIs) are typically extremely hard to treat,[i] but this new research finds that photodisinfection may be an exciting new treatment approach. The research team, lead by PD Dr. med. Yvonne Achermann is planning further clinical research on the safety and efficacy of the PJI treatment. ...

ByOndine Biomedical Inc


MerLion Pharmaceuticals Announces Successful FDA Type C Meeting for the Systemic Application of the Antibiotic Finafloxacin Against Infections caused by Burkholderia pseudomallei (Melioidosis)

MerLion Pharmaceuticals Announces Successful FDA Type C Meeting for the Systemic Application of the Antibiotic Finafloxacin Against Infections caused by Burkholderia pseudomallei (Melioidosis)

MerLion Pharmaceuticals GmbH (MerLion), a pharmaceutical company focused on the development of novel antibiotics, reported the receipt of the final meeting minutes from the U.S. Food and Drug Administration (FDA) following a successful Type C meeting with the Agency on the development of the antibiotic finafloxacin for the treatment of ...

ByMerLion Pharmaceuticals GmbH


Diasorin launches Liaison MeMed BV, the first high throughput blood test to differentiate between bacterial and viral infections, in countries accepting the CE Mark

Diasorin launches Liaison MeMed BV, the first high throughput blood test to differentiate between bacterial and viral infections, in countries accepting the CE Mark

The LIAISON MeMed BV test is the first fully automated solution, which utilizes host response-based data to enable physicians to differentiate accurately between bacterial and viral infections, supporting fast and better-informed treatment and patient management decisions. The test also drives laboratory operational efficiency through time-labor reduction by using a fully ...

ByMeMed


OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine

OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine

208 patients enrolled in a prospective, randomized, controlled, multicenter, interventional trial Unyvero reduced the use of inappropriate antibiotic therapy by 45%, shortened inappropriate antibiotic therapy by 39 hours, and reduced overall antibiotic therapy duration by 22.5% Unyvero results combined with antibiotic ...

ByOpGen, Inc.


Seres Therapeutics Presents Phase III Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

Seres Therapeutics Presents Phase III Results of SER-109 for Recurrent C. Difficile Infection at the Digestive Disease Week (DDW) Annual Meeting

A pre-planned exploratory analysis from the ECOSPOR III trial shows that approximately two-thirds of CDI recurrences occurred within the first two weeks following antibiotic treatment for CDI – the window of vulnerability – when the microbiome is further decimated and C. difficile spores, untouched by antibiotics, are free to ...

BySeres Therapeutics, Inc.


The transformation of precision medicine in infectious disease

The transformation of precision medicine in infectious disease

Before Alexander Fleming discovered penicillin, another more selective antibacterial agent rose to popularity in the early 1900s: bacteriophage. In 1917, microbiologist Felix d’Herelle was tasked with identifying the cause of a dysentery outbreak impacting French troops. From his research, he noticed that Shigella bacteria was the primary culprit of this affliction. He then discovered an ...

ByLocus Biosciences, Inc.


CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference

CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference

” Infective endocarditis is a potentially life-threatening infection of one or more heart valves that is usually caused when bacteria enter the bloodstream due to a systemic infection, dental care, or intravenous drug abuse and the use of dirty needles. Treatment typically involves antibiotics, but for many patients, cardiac surgery and valve replacement ...

ByCytoSorbents Corporation


Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA

Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA

” Recurrent CDI causes approximately half a million infections each year in the United States, including up to 165,000 recurring infections and up to 45,000 deaths. Existing treatments include antibiotics, which can further damage the gut microbiome. ...

ByVedanta Biosciences, Inc


Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award

Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award

Unfortunately, many medications, such as anticancer, antibiotics, and antifungal treatments, have severe toxicities when overdosed and are ineffective when underdosed. ...

BySaladax Biomedical, Inc.


Towards a cure for Mycobacterium abscessus disease using inhaled tigecycline

Towards a cure for Mycobacterium abscessus disease using inhaled tigecycline

The pathogen is also known as the ‘antibiotic nightmare’, due to its resistance to nearly all antibiotics. ...

ByPureims B.V.


New Accelerate Pheno Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021

New Accelerate Pheno Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021

The data further highlight the clinical benefits of using the Accelerate Pheno system, with significant improvements in multiple endpoints, including a statistically significant reduction in 30-day mortality in the Accelerate Pheno arm (AXDX) versus standard of care testing arm (SOC) in a subset of patients on ineffective empirical antibiotic treatment (6.0% in ...

ByAccelerate Diagnostics, Inc.


Creative Enzymes Launches Anti Helicobacter Pylori Formula for Academic and Industrial Use

Creative Enzymes Launches Anti Helicobacter Pylori Formula for Academic and Industrial Use

Helicobacter pylori (H. pylori) has been confirmed to be closely related to chronic gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue lymphoma and gastric cancer. At present, the combined treatment of multiple antibiotics is still the main method of anti-H. pylori infection, but the emergence of bacterial resistance and the long-term unreasonable ...

ByCreative Enzymes


Eligo Presents Preclinical Data Demonstrating for the First Time that Gut Microbiome Modulation via Delivery of CRISPR Nuclease Impacts Disease Progression

Eligo Presents Preclinical Data Demonstrating for the First Time that Gut Microbiome Modulation via Delivery of CRISPR Nuclease Impacts Disease Progression

The EB003 CRISPR-based killing mechanism also abolished Shiga-toxin production, compared to antibiotic treatment, which can on the contrary lead to Shiga-toxin overproduction. ...

ByEligo Bioscience


MerLion Pharmaceuticals Completes Growth Financing Round

MerLion Pharmaceuticals Completes Growth Financing Round

MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics for the treatment of serious bacterial infections, today announced the successful completion of a growth financing round raised via a private placement to European strategic investors. ...

ByMerLion Pharmaceuticals GmbH


MediPrint™ Ophthalmics Announces Promising Results From Its Primary Market Research

MediPrint™ Ophthalmics Announces Promising Results From Its Primary Market Research

The post-cataract surgery lens may be able to deliver a combination corticosteroid, NSAID and antibiotic treatment from a single lens. Ophthalmologists will apply the lens after the cataract surgery and patients can wear the lens for one week or longer to deliver the medication, instead of needing to use multiple eye drops every day. ...

ByMediprint Ophthalmics

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT